Pharmacom Biovet Inc
OTC:PHMB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shijiazhuang ChangShan BeiMing Technology Co Ltd
SZSE:000158
|
CN |
Pharmacom Biovet Inc
Common Stock
Pharmacom Biovet Inc
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pharmacom Biovet Inc
OTC:PHMB
|
Common Stock
$23k
|
CAGR 3-Years
32%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Universal Health Services Inc
NYSE:UHS
|
Common Stock
$611k
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-5%
|
|
|
Encompass Health Corp
NYSE:EHC
|
Common Stock
$1.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
|
Tenet Healthcare Corp
NYSE:THC
|
Common Stock
$8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
|
HCA Healthcare Inc
NYSE:HCA
|
Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ensign Group Inc
NASDAQ:ENSG
|
Common Stock
$62k
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-5%
|
|
Pharmacom Biovet Inc
Glance View
PharmaCom BioVet, Inc. engages in the provision of locating, identifying, and introducing cancer compounds and treatment procedures into the veterinary market. The company is headquartered in Raleigh, North Carolina and currently employs 2 full-time employees. The company went IPO on 2001-06-06. The firm is introducing canine bone marrow transplantation. ABV Gold Inc. was a gold and precious metals mining company founded as an exploration company to locate, explore and mine deposits. The firm holds claims in three different properties: The Toiyabe Uranium, the Parin Mining, and the Dun Glen properties.
See Also
What is Pharmacom Biovet Inc's Common Stock?
Common Stock
23k
USD
Based on the financial report for Sep 30, 2004, Pharmacom Biovet Inc's Common Stock amounts to 23k USD.
What is Pharmacom Biovet Inc's Common Stock growth rate?
Common Stock CAGR 5Y
18%
Over the last year, the Common Stock growth was -57%. The average annual Common Stock growth rates for Pharmacom Biovet Inc have been 32% over the past three years , 18% over the past five years .
